Litigation Details for Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)
✉ Email this page to a colleague
Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-09-15 |
| Court | United States Bankruptcy Court, S.D. New York | Date Terminated | |
| Cause | Assigned To | Sean H. Lane | |
| Jury Demand | Referred To | ||
| Parties | PURDUE PHARMA L.P. | ||
| Patents | 10,407,434; 6,488,963; 7,658,945; 8,269,040; 8,313,778; 8,337,888; 8,722,684; 9,023,391; 9,060,976; 9,073,933; 9,522,919 | ||
| Attorneys | Nhan Huynh Nguyen | ||
| Firms | Reed Smith LLP, Reed Smith Centre | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Purdue Pharma L.P.
Biologic Drugs cited in Purdue Pharma L.P.
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-07-20 | 1463 | Response to Motion | ,412, as U.S. Patent Nos. 8,337,888 (the “’888 patent”); 9,060,976 (the “’976 patent”); and 9,034,376…certain of the Debtors’ patents, including U.S. Patent No. 9,693,961 (“the ’961 Patent”). Shortly after the… Patent 9,693,961 B2 A. Related Proceedings Patent Owner asserted the ’961 patent against…Response, Patent Owner contends that, “transitional” continuation patents such as the ’961 patent are not…before the Patent Trial and Appeal Board (the “PTAB”), seeking a determination that the ’961 patent was invalid | External link to document |
| 2020-08-19 | 1592 | Objection to Motion | other patents in suit – U.S. Patent Nos. 9,073,933 (“’933 Patent”) and 9,522,919 (“’919 Patent”). These…of one of the Debtors’ patents, U.S. Patent No. 9,693,961 B2 (the “’961 Patent”). Collegium’s Response…’961 Patent — the subject of the PTAB Action — is just one of the patents in suit in the Patent Litigation…Action”) before the United States Patent and Trademark Office’s Patent Trial and Appeal Board (the “PTAB…These patents are not related to the ’961 Patent — they have different specifications, different records | External link to document |
| 2021-01-11 | 2247 | Exhibit 15 | U.S.P.N.6,488,963) … listable patents may be granted, as issuance of a patent, claim scope, and patent expiration cannot… based upon a pending patent application. • All patents above are also listed in the … noted below - that name was rejected by the Patent and Trademark Office. In order to maintain brand…application for T ARGIN was rejected by the United States Patent and Trademark Office based on similarity | External link to document |
| 2019-10-29 | 357 | Schedules | ATTN: GENERAL COUNSEL U.S. PAT. NO. 7,658,945 DATED MARCH …relating to patent litigation Undetermined Nature of claim: Patent Litigation…relating to patent litigation Undetermined Nature of claim: Patent Litigation…relating to patent litigation Undetermined Nature of claim: Patent Litigation …relating to patent litigation Undetermined Nature of claim: Patent Litigation | External link to document |
| 2019-10-29 | 382 | Schedules | ATTN: GENERAL COUNSEL U.S. PAT. NO. 7,658,945 DATED MARCH … (Where available) 60. Patents, copyrights, trademarks, and trade secrets … (Where available) 60. Patents, copyrights, trademarks, and trade secrets … WYOMING, DE 2. 38 AMENDMENT NO. 1 TO THE PATENT 103988 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
